Anne Mühlig

Anne Mühlig is a Medical Specialist in Pediatrics and Youth Medicine at the University Medical Center Hamburg-Eppendorf (UKE), affiliated with the University of Hamburg. She is based in the Center for Obstetrics and Pediatrics, Department of Pediatrics, where she focuses on pediatric nephrology and kidney-related disorders in children.

Dr. Mühlig's research spans several critical areas in pediatric kidney diseases. Her work on podocyte biology has revealed how these specialized cells become damaged in conditions like Fabry disease and focal segmental glomerulosclerosis. She has made significant contributions to understanding the complement system's role in kidney pathology, demonstrating that podocytes themselves produce and secrete functional complement components. Her research on genetic kidney disorders and precision medicine approaches aims to develop individualized therapies for children with nephrological conditions.

Analysis of her publication record shows a strong emphasis on translational research connecting basic science discoveries with clinical applications. Her most recent work includes developing optimized multiomics protocols for kidney tissue analysis (2024), investigating calcium-sensing receptors in proteinuric conditions (2022), and exploring novel therapeutic approaches like levamisole for nephrotic syndrome (2019). Her research frequently employs advanced techniques including molecular biology, immunohistochemistry, and animal models to understand disease mechanisms.

Dr. Mühlig is an active member of the scientific community through her memberships in the American Society of Nephrology and the Gesellschaft für pädiatrische Nephrologie. Her work has been consistently published in high-impact journals including Kidney International, Journal of Clinical Investigation, and Frontiers in Immunology.

As a clinician-scientist, Dr. Mühlig maintains dual expertise in patient care and research. She is fluent in both German (her native language) and English, enabling international collaboration and presentation at global conferences. Her ongoing research continues to advance our understanding of pediatric kidney diseases and improve treatment options for young patients.